OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effects of colchicine on risk of cardiovascular events and mortality among patients with gout: a cohort study using electronic medical records linked with Medicare claims
Daniel H. Solomon, Chih‐Chin Liu, I‐Hsin Kuo, et al.
Annals of the Rheumatic Diseases (2015) Vol. 75, Iss. 9, pp. 1674-1679
Open Access | Times Cited: 132

Showing 1-25 of 132 citing articles:

2020 American College of Rheumatology Guideline for the Management of Gout
John FitzGerald, Nicola Dalbeth, Ted R. Mikuls, et al.
Arthritis Care & Research (2020) Vol. 72, Iss. 6, pp. 744-760
Open Access | Times Cited: 654

2020 American College of Rheumatology Guideline for the Management of Gout
John FitzGerald, Nicola Dalbeth, Ted R. Mikuls, et al.
Arthritis & Rheumatology (2020) Vol. 72, Iss. 6, pp. 879-895
Open Access | Times Cited: 553

Major adverse cardiovascular event definitions used in observational analysis of administrative databases: a systematic review
Elliott Bosco, Leon Hsueh, Kevin W. McConeghy, et al.
BMC Medical Research Methodology (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 302

Update on colchicine, 2017
Anastasia Slobodnick, Binita Shah, Svetlana Krasnokutsky, et al.
Lara D. Veeken (2017) Vol. 57, Iss. suppl_1, pp. i4-i11
Open Access | Times Cited: 225

Colchicine: an ancient drug with novel applications
Bahar Dasgeb, Davida Kornreich, Kathleen P. McGuinn, et al.
British Journal of Dermatology (2017) Vol. 178, Iss. 2, pp. 350-356
Open Access | Times Cited: 186

Cardiovascular risk in inflammatory arthritis: rheumatoid arthritis and gout
Romy Hansildaar, Daisy Vedder, Milad Baniaamam, et al.
The Lancet Rheumatology (2020) Vol. 3, Iss. 1, pp. e58-e70
Open Access | Times Cited: 184

Colchicine in Cardiovascular Disease: In-Depth Review.
Spyridon Deftereos, Frans Beerkens, Binita Shah, et al.
PubMed (2022) Vol. 145, Iss. 1, pp. 61-78
Closed Access | Times Cited: 166

Colchicine and the heart
Massimo Imazio, Mark Nidorf
European Heart Journal (2021) Vol. 42, Iss. 28, pp. 2745-2760
Open Access | Times Cited: 151

Anti-inflammatory therapy for COVID-19 infection: the case for colchicine
Aaron Reyes, Kelly A Hu, Jacob Teperman, et al.
Annals of the Rheumatic Diseases (2020) Vol. 80, Iss. 5, pp. 550-557
Open Access | Times Cited: 140

Colchicine’s Role in Cardiovascular Disease Management
Leo F. Buckley, Peter Libby
Arteriosclerosis Thrombosis and Vascular Biology (2024) Vol. 44, Iss. 5, pp. 1031-1041
Closed Access | Times Cited: 25

2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes
Sunil V. Rao, Michelle L. O’Donoghue, Marc Ruel, et al.
Journal of the American College of Cardiology (2025)
Closed Access | Times Cited: 4

Colchicine Improves Survival, Left Ventricular Remodeling, and Chronic Cardiac Function After Acute Myocardial Infarction
Koichiro Fujisue, Koichi Sugamura, Hirofumi Kurokawa, et al.
Circulation Journal (2017) Vol. 81, Iss. 8, pp. 1174-1182
Open Access | Times Cited: 113

Colchicine for Secondary Prevention of Cardiovascular Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Michelle Samuel, Jean‐Claude Tardif, Nadia Bouabdallaoui, et al.
Canadian Journal of Cardiology (2020) Vol. 37, Iss. 5, pp. 776-785
Closed Access | Times Cited: 100

INTERDISCIPLINARY CLINICAL PRACTICE GUIDELINES "MANAGEMENT OF OBESITY AND ITS COMORBIDITIES"
И. И. Дедов, Marina V. Shestakova, G. А. Melnichenko, et al.
Obesity and metabolism (2021) Vol. 18, Iss. 1, pp. 5-99
Open Access | Times Cited: 98

The effect of low-dose colchicine in patients with stable coronary artery disease: The LoDoCo2 trial rationale, design, and baseline characteristics
Stefan M. Nidorf, Aernoud T.L. Fiolet, John W. Eikelboom, et al.
American Heart Journal (2019) Vol. 218, pp. 46-56
Closed Access | Times Cited: 95

Uric Acid Is Associated With Inflammation, Coronary Microvascular Dysfunction, and Adverse Outcomes in Postmenopausal Women
Megha Prasad, Eric L. Matteson, Joerg Herrmann, et al.
Hypertension (2016) Vol. 69, Iss. 2, pp. 236-242
Open Access | Times Cited: 92

Consensus Statement Regarding the Efficacy and Safety of Long-Term Low-Dose Colchicine in Gout and Cardiovascular Disease
Philip C. Robinson, Robert Terkeltaub, Michael H. Pillinger, et al.
The American Journal of Medicine (2021) Vol. 135, Iss. 1, pp. 32-38
Open Access | Times Cited: 78

Update on the Role of Colchicine in Cardiovascular Disease
Darcy Banco, Mohammad Hashim Mustehsan, Binita Shah
Current Cardiology Reports (2024) Vol. 26, Iss. 4, pp. 191-198
Closed Access | Times Cited: 9

An injectable thermosensitive hydrogel loaded with an ancient natural drug colchicine for myocardial repair after infarction
Yu Chen, Jiayue Shi, Yaping Zhang, et al.
Journal of Materials Chemistry B (2019) Vol. 8, Iss. 5, pp. 980-992
Closed Access | Times Cited: 72

Comparative cardiovascular risk in users versus non-users of xanthine oxidase inhibitors and febuxostat versus allopurinol users
Chengsheng Ju, Rachel Wing Chuen Lai, Ka Hou Christien Li, et al.
Lara D. Veeken (2019) Vol. 59, Iss. 9, pp. 2340-2349
Open Access | Times Cited: 71

Arteriosclerosis e inflamación. Nuevos enfoques terapéuticos
Juan Pedro‐Botet, Elisenda Climent, David Benaiges
Medicina Clínica (2020) Vol. 155, Iss. 6, pp. 256-262
Closed Access | Times Cited: 70

2020 recommendations from the French Society of Rheumatology for the management of gout: Urate-lowering therapy
Tristan Pascart, Augustin Latourte, René‐Marc Flipo, et al.
Joint Bone Spine (2020) Vol. 87, Iss. 5, pp. 395-404
Open Access | Times Cited: 68

Failure to reach uric acid target of <0.36 mmol/L in hyperuricaemia of gout is associated with elevated total and cardiovascular mortality
Fernando Perez‐Ruiz, Pascal Richette, Austin G. Stack, et al.
RMD Open (2019) Vol. 5, Iss. 2, pp. e001015-e001015
Open Access | Times Cited: 59

Colchicine for acute and chronic coronary syndromes
Massimo Imazio, Alessandro Andreis, Antonio Brucato, et al.
Heart (2020) Vol. 106, Iss. 20, pp. 1555-1560
Open Access | Times Cited: 55

Page 1 - Next Page

Scroll to top